Flow
Customer Insights

NMR in Pharma

Pharmaceutical research demands precision, reliability, and deep molecular insight. In this section, we highlight how our customers are advancing drug discovery, development, and quality control through innovative applications of NMR. Their pioneering work showcases the essential role of magnetic resonance in shaping the future.

Collaboration with the University of Barcelona

Collaboration Between the University of Barcelona and Bruker to Advance Characterization of Therapeutic Monoclonal Antibodies and Oligonucleotides Using 1 GHz NMR Technology

The University of Barcelona and Bruker have partnered to advance pharmaceutical research through the use of 1 GHz NMR technology. This collaboration aims to enhance the characterization of therapeutic monoclonal antibodies and oligonucleotides by leveraging cutting-edge NMR techniques and high-field instrumentation.

PIPAc

Controlling chemical reactions with Artificial Intelligence (AI)

The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and location-independent API manufacturing solution to a pharmaceutical company or contract manufacturing organization.

We interviewed each of the partners to learn more about this innovative project.

 

PIPAc project overview video

Interview Julien Marin, Director Research Services Novalix

Interview Julien Marin, Director Research Services Novalix, Strasbourg, France

Interview Philippe Robin, President Alysophil SAS
 

Interview Philippe Robin, President Alysophil SAS, Strasbourg, France

Interview Luis Carrillo, Managing Director DeDietrich Pharma & Green Solutions

Interview Luis Carrillo, Managing Director DeDietrich Pharma & Green Solutions, Strasbourg, France

Interview Anna Codina, Director Pharmaceutical Business Unit, Bruker BioSpin

Interview Anna Codina, Director Pharmaceutical Business Unit, Bruker BioSpin, Ettlingen, Germany